 Gestonorone caproate is used in the palliative treatment of benign prostatic hypertrophy and endometrial cancer.It is used at a dose of 100 to 200 mg once a week by intramuscular injection.Side effects of gestonorone caproate have been reported to include worsened glucose tolerance, decreased libido in men, and local injection site reactions such as irritation.